F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Life Technologies Corporation operates as a biotechnology tools company. The company's systems, consumables and services enable researchers to accelerate scientific exploration, to discoveries and developments. Life Technologies was created by the combination of [Invitrogen Corporation](/organization/invitrogen) and [Applied Biosystems, Inc.](/organization/applied-biosystems) in November of 2008, and Life Technologies continues to serve its customers under those two well-known brands. Invitrogen is the premier provider of reagents and consumables that are usable across multiple platforms, while Applied Biosystems remains the top provider of systems-based, end-to-end solutions in areas such as PCR, genetic sequencing, and mass spectrometry. The company delivers a range of products and services, including systems, instruments, reagents, and custom services. Its portfolio of products includes technologies for capillary electrophoresis based sequencing, sequencing, mass spectrometry, sample preparation, cell culture, RNA interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications and water testing analysis.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom.

Frame Pharmaceuticals BV, part of CureVac NV, is a company headquartered in Amsterdam, the Netherlands, that offers cancer therapy services. It was founded by Bob L��wenberg and Ronald Plasterk. Ronald Plasterk is the current CEO, occupying that position since 2018. CureVac NV acquired Frame Pharmaceuticals BV on June 08, 2022 for $34.26 million.\nThe company says this about itself: Frame Cancer Therapeutics is a privately funded startup company in the Amsterdam Science Park founded in December 2018. Frame Therapeutics�� goal is to develop its proprietary approach for immunotherapy against cancer, which is based on precise analysis of the DNA and RNA of the tumor of a patient and using that information to supply the best vaccine against properties specific for the tumor. The strong anti-tumor immune response elicited by Frame vaccines may contribute to major clinical benefits for patients with diverse forms of cancer.

Polish Stem Cell Bank (PBKM) is the largest stem cell bank in Poland and Europe. We store biological material from customers from dozens of European countries. We also have the most experience in transferring material for transplantation. Our mission is to provide access to innovative treatment from harvested stem cells to save the life and health of your child or other family members. Our primary goal is to extract and store stem cells from cord, placental and umbilical cord. The continuous implementation of this goal is confirmed by extensive, documented experience in the transfer of stem cells for transplantation in Poland and abroad. At every stage of our business, we strive to meet the highest technological and ethical standards to give our customers the confidence to choose a Partner they can trust for years to come. At the Polish Stem Cell Bank, we believe that being a responsible company is right not only for the development of our business, but above all for parents who give us in storage valuable material collected during childbirth.

Zhiben Medical Technology (Shanghai) Co. Ltd. (doing business as OrigiMed) is a company headquartered in Shanghai, China. The firm develops medical science and technology transforming application. It was founded in 2016.\nThe company says this about itself: OrigiMed is a precision medicine company focusing on high-tech R&D with a global vision and the knowledge transfer in the clinical practice of cancers. With the commitment to developing hundreds of cancer genomic tests, the company strive to provide comprehensive and accurate molecular information to every patient and help doctors with their precision medicine practice. OrigiMed aims to promote the innovation in the way of clinical treatment for cancer in China. At OrigiMed, patients' molecular changes are identified by the stringently verified CGP and matched with approved targeted therapies, immunotherapies, and clinical trials. OrigiMed closely collaborates with global and domestic biopharmaceutical companies to help with new drug development and approvals.

Beijing Akron Medical Technology Co., Ltd., established on 2015-01-20, Business scope includes health food business;technology development,technology transfer,technical consulting,Technical Services,Technology Promotion;computer technology training;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;business management;investment management,asset Management;Tax Consulting;market survey;Economic and Trade Consulting,Investment Advisory,Business Management Consulting,buisness planning,design,Educational Consulting(No intermediary services);design,make,acting,Place an ad;Conference Services,Undertake the exhibition;packaging service;translation service;product design;Package Design;arts and crafts design;computer animation design;Family labor service;Sales of medical devices;production of medical devices;Import and export,Technology Import and Export,Agent import and export;health management,Health Advisory(Except for medical treatment activities subject to approval);food business(Only sell prepackaged food);(business premises:Baifuquan Road, Science and Technology Park, Changping District, Beijing10Xingye Building6FloorB-3Compartment).(Market entities independently choose business projects in accordance with the law,Carry out business activities;and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Wojskowy Instytut Medyczny is a government research and development unit and a public healthcare facility that also offers PG in medicine.

Beijing Computing Center Co., Ltd., established on 2000-12-21, Business scope includes computer software and hardware,computer network,electronic product,Communication Products,Data Processing and Engineering,Technology development of new materials,technology transfer,technical consulting,Technical Training,Technical Services;Sales of developed products;property management(Office for rent);Computer System Services;Basic software service;Application software service;data processing;Rental machinery and equipment;computer technology training;Conference Services;Undertake the exhibition;selling computers,Software and Auxiliary Equipment;Technical testing.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

Khloris Biosciences, Inc. is a biotechnology company based in the Bay Area dedicated to revolutionizing medical treatment of cardiovascular and other diseases with high unmet need with their proprietary platform of disease-specific induced pluripotent stem cells (iPSCs) for innovative drug screening and discovery.

Neoantigen is a high-tech and innovative enterprise specializing in the research and development of individualized tumor vaccines. It is committed to developing various individualized immunotherapy products based on neoantigens. The founder of the company proposed the concept of neoantigen-based therapy in China in 2005 and is one of the leaders in the research and development of neoantigen-related products in the world.

Caris Molecular Profiling Institute, Inc. provides research and laboratory testing services. It offers tests to help oncologists to understand and treat cancer patients with personalized treatment plans based on the molecular characteristics of their tumors. The company offers services to the hospitals, physicians, and clinical research sponsors. Caris Molecular Profiling Institute was founded on 1996 and is headquartered in Phoenix, AZ.